Laser lead extraction for patient suffering with Automated Implantable Cardioverter-Defibrillator (AICD) infection and subsequent implantation of new system as subcutaneous AICD (S-ICD) at cardiac catheterization lab, Her Majesty Cardiac Center, Faculty of Medicine Siriraj Hospital

Authors

  • ชัชญาภา ศรีพรม ศูนย์โรคหัวใจสมเด็จพระบรมราชินีนาถ
  • Supaluck Kanjanauthai
  • Anon Jantanukul
  • Kanok-on Chamnan
  • Atchara Pumsombat

Keywords:

Automated Implantable Cardioverter-Defibrillator (AICD), Laser lead extraction, Subcutaneous Implantable Cardioverter-Defibrillator, S-ICD Correspondence to: Chatyapha Sriprom

Abstract

Patient whom sustained cardiac arrest from ventricular arrhythmia such as ventricular tachycardia or ventricular fibrillation required immediate treatment with defibrillation to save life. During defibrillation by external defibrillator, heart will receive electrical energy to convert disorganize rhythm into organize rhythm therefore heart could become beating again. According to 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary(5) , automated implantable cardioverted defibrillator (AICD) implantation is being performed on selected patients as primary or secondary prevention for sudden cardiac death. General concept of AICD implantation is to have AICD battery or generator place underneath skin  at pre-pectoral space but in rare occasions it is placed underneath muscle layer. AICD lead is placed through venous access and fixed to patient’s heart. Overall complications following this procedure reported to be less than 5% from local data(1) including bleeding and infection. Infection of AICD system is considered a serious complication which required explantation of the device to mitigate risk of infective endocarditis. During explantation, lead extraction maybe challenging due to lead adhesion which can be overcome by using laser lead extraction system (class I indication according to 2018 EHRA expert consensus statement on lead extraction)(3,4). After removal of infected AICD system and elimination of infection is ensured, new AICD system will be re-implanted. In some selected patients may be suitable for subcutaneous implantable cardioverter defibrillator (S-ICD) . S-ICD has entire system placed subcutaneously therefore, this would help reduce risk of infective endocarditis as no venous access required.

References

ชญานุตม์ สุวรรณเพ็ญ. เครื่องกระตุกไฟฟ้าหัวใจอัตโนมัติชนิดถาวร (Automated Implantable Cardioverter-Defibrillator, AICD) [อินเทอร์เน็ต]. 2013; สืบค้นเมื่อ10 ก.ค. 2564. จาก http://www.chulacardiaccenter.org/en/component/content/article/251-aicd.

ปิยภัทร ชุณหรัศมิ์, ธีรภัทร ยิ่งชนม์เจริญ, ระพีพล กุญชร ณ อยุธยา. แนวทางเวชปฏิบัติเพื่อการวินิจฉัยและการ ดูแลรักษาผู้ป่วยภาวะหัวใจล้มเหลว. (พิมพ์ครั้งที่1). สมุทรปราการ : ห้างหุ้นส่วนจํากัด เนคสเตป ดีไซน์; 2562.

Adryan A Perez, Frank W Woo, Darren C Tsang, and Roger G Carrillo. Transvenous Lead Extractions: Current Approaches and Future Trends. Arrhythmia Electrophysiology Review. 2018; 7(3): 210–217.

Maria G. Bongiorni (Chair), Haran Burri (Co-chair), Jean C. Deharo, Christoph Starck, Charles Kennergren, Laszlo Saghy, et al . 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. European Society of Cardiology. 2018; (20): 1217a-1217j.

Sena M. AI-Khatib, William G. Stevenson, Michael J. Ackerman, William J. Bryant, David J. Callans, Anne B. Curtis, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 2018;138:e272–e391.

Spectranetics, Inc. Lead Management Using Spectranetics Laser Technology , USA. 2011;32-45

Stefano Cappelli, Alina Olaru, Elia De Maria. The subcutaneous defibrillator: who stands to benefit. European Society of Cardiology. 2014;12:17

Zak Loring, Emily P Zeitler, Daniel J Friedman, Kristen B Campbell, Sarah A Goldstein, Zachary K Wegermann, et al. Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE. Heart Rhythm. 2020;17(3):447-454.

Downloads

Published

2022-04-30

How to Cite

ศรีพรม ช., Kanjanauthai, S. ., Jantanukul, A. ., Chamnan, K.- on ., & Pumsombat, A. . (2022). Laser lead extraction for patient suffering with Automated Implantable Cardioverter-Defibrillator (AICD) infection and subsequent implantation of new system as subcutaneous AICD (S-ICD) at cardiac catheterization lab, Her Majesty Cardiac Center, Faculty of Medicine Siriraj Hospital. Mahasarakham Hospital Journal, 19(1), 15–22. retrieved from https://he02.tci-thaijo.org/index.php/MKHJ/article/view/252727